Experienced in Progressive Supranuclear Palsy Atypical

Alexandre Eusebio

Marseille, FR 
Experienced in Progressive Supranuclear Palsy Atypical
Marseille, FR 
OverviewLocationsClinical Research

Overview

Alexandre Eusebio practices in Marseille, France. Mr. Eusebio is rated as an Experienced expert by MediFind in the treatment of Progressive Supranuclear Palsy Atypical. His top areas of expertise are Parkinson's Disease, Movement Disorders, Dysgraphia, Deep Brain Stimulation, and Thalamotomy.

His clinical research consists of co-authoring 77 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Progressive Supranuclear Palsy Atypical.

Gender
Male

Locations

Marseille, France
Other Locations
Aix-en-provence, France
NS Park French Network, Lille, France
France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Predictive Factors for Therapeutic Response of Subthalamic Stimulation on Quality of Live in Parkinson's Disease
Predictive Factors for Therapeutic Response of Subthalamic Stimulation on Quality of Live in Parkinson's Disease
Enrollment Status: Active_not_recruiting
Publish Date: November 07, 2022
Intervention Type: Other
Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease. European Multicentre, Parallel-group, Placebo-controlled, Randomized Clinical Trial of Deferiprone
Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease. European Multicentre, Parallel-group, Placebo-controlled, Randomized Clinical Trial of Deferiprone
Enrollment Status: Completed
Publish Date: November 07, 2022
Intervention Type: Drug
Study Drug: Deferiprone
Study Phase: Phase 2
Evaluate the Long-term (3 Months) Efficacy of L-threo DOPS (DroxiDopa) on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With Multiple System Atrophy (MSA). Comparative Study Versus Placebo
Evaluate the Long-term (3 Months) Efficacy of L-threo DOPS (DroxiDopa) on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With Multiple System Atrophy (MSA). Comparative Study Versus Placebo
Enrollment Status: Completed
Publish Date: August 25, 2020
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Treatment of Severe and Resistant Obsessive-compulsive Disorder by High-frequency Stimulation of the Ventral Striatum and the Subthalamic Nucleus
Treatment of Severe and Resistant Obsessive-compulsive Disorder by High-frequency Stimulation of the Ventral Striatum and the Subthalamic Nucleus
Enrollment Status: Completed
Publish Date: February 06, 2020
Intervention Type: Procedure
Study Phase: Phase 3
View 3 Less Clinical Trials

77 Total Publications

Exploring the link between personality dimensions and non-motor fluctuations in Parkinson's disease.
Exploring the link between personality dimensions and non-motor fluctuations in Parkinson's disease.
Journal: Journal of Parkinson's disease
Published: June 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Eusebio's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile